Accedi Non sei ancora Registrato?

Iscriviti per ricevere i nostri articoli via email in tempo reale

Oops! We could not locate your form.

Chi Siamo
Portolano Cavallo concentra la propria attività nel settore TMT sin dalla sua nascita nel 2001 ed è ora riconosciuto come lo studio legale italiano leader in questo settore.
Lo Studio
Portolano Cavallo Studio Legale was founded in 2001 by partners Manuela Cavallo and Francesco Portolano. The firm’s activity is mainly focused on the corporate/M&A sector and the media industry.
Eng / Ita

Contenuti inseriti nel mese di July 2018

Jul 30

Patent Linkage: Administrative Court of Lazio rules SPC extension does not apply to combinations of patented active ingredients with other molecules

With a decision pronounced on 5 July 2018, the Regional Administrative Court (TAR) of Lazio upheld an appeal filed by Doc Generici S.r.l., an Italian pharmaceutical company that specializes in the development, manufacturing and sale of generic drugs. In the case, the appellant impugned the Italian Medicines Agency’s (AIFA) classification of an ezetimibe/simvastatin-based drug combination… continua

Articolo inserito in: Intellectual Property
Jul 25

In a first, the EU Commission fines four consumer electronics manufacturers EUR 111m for Resale Price Maintenance

Yesterday the European Commission imposed fines for EUR 111 million in aggregate to four consumer electronics manufacturers for fixing distributors’ resale prices of their products on the internet, a commercial practice commonly referred to as Resale Price Maintenance (or RPM). RPM is a conduct by which suppliers restrict, contractually or through other behavior, the ability… continua

Articolo inserito in: Regulatory, Antitrust
Jul 18

The European Court of Justice addresses parallel Imports of pharmaceuticals under the Specific Mechanism established in the Accession Treaties for new Member States

The reference for a preliminary ruling made by the District Court of Düsseldorf (Landgericht) followed a heated dispute between Pfizer Ireland Pharmaceuticals, Operations Support Group (Pfizer) and Orifarm GmbH (Orifarm) concerning parallel imports of Enbrel, a genetically engineered protein for the treatment of arthritis. The appellant – proprietor of a supplementary protection certificate (SPC) for… continua

Jul 5

European Commission proposes to amend current SPC Regulation

The European Commission recently proposed an amendment to the supplementary protection certificate (SPC), a key regulation that grants additional intellectual property rights to patent holders on a wide range of biologically active compounds such as medicaments, veterinary drugs, herbicides and insecticides. The draft legislation, which was presented on 28 May 2018, calls for an “export… continua